[go: up one dir, main page]

EG20104A - Process for extraction of pharmaceutically active compositions from tanactum parathenium and medicament prepared from them - Google Patents

Process for extraction of pharmaceutically active compositions from tanactum parathenium and medicament prepared from them

Info

Publication number
EG20104A
EG20104A EG5293A EG5293A EG20104A EG 20104 A EG20104 A EG 20104A EG 5293 A EG5293 A EG 5293A EG 5293 A EG5293 A EG 5293A EG 20104 A EG20104 A EG 20104A
Authority
EG
Egypt
Prior art keywords
extraction
pharmaceutically active
tanactum
parathenium
active compositions
Prior art date
Application number
EG5293A
Other languages
English (en)
Original Assignee
Chabeeer & Bromio Mbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6450610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG20104(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chabeeer & Bromio Mbh & Co Kg filed Critical Chabeeer & Bromio Mbh & Co Kg
Application granted granted Critical
Publication of EG20104A publication Critical patent/EG20104A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
EG5293A 1992-01-31 1993-01-26 Process for extraction of pharmaceutically active compositions from tanactum parathenium and medicament prepared from them EG20104A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4202657A DE4202657C2 (de) 1992-01-31 1992-01-31 Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel

Publications (1)

Publication Number Publication Date
EG20104A true EG20104A (en) 1997-07-31

Family

ID=6450610

Family Applications (1)

Application Number Title Priority Date Filing Date
EG5293A EG20104A (en) 1992-01-31 1993-01-26 Process for extraction of pharmaceutically active compositions from tanactum parathenium and medicament prepared from them

Country Status (19)

Country Link
US (1) US5466451A (ru)
EP (1) EP0553658B2 (ru)
JP (1) JP3611869B2 (ru)
CN (1) CN1074927C (ru)
AT (1) ATE150314T1 (ru)
BR (1) BR9300361A (ru)
CA (1) CA2088289C (ru)
CZ (1) CZ286486B6 (ru)
DE (2) DE4202657C2 (ru)
DK (1) DK0553658T4 (ru)
EG (1) EG20104A (ru)
ES (1) ES2099296T5 (ru)
GR (1) GR3023202T3 (ru)
HU (1) HUT64232A (ru)
MX (1) MX9300265A (ru)
PL (1) PL171097B1 (ru)
RU (1) RU2104017C1 (ru)
SK (1) SK279652B6 (ru)
UA (1) UA26917C2 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695931B1 (fr) * 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
WO1999033463A1 (en) * 1997-12-23 1999-07-08 Moser, René SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b)
DE19800330C2 (de) * 1998-01-07 2002-09-26 Delta 9 Pharma Gmbh Pharmazeutisch wirksamer CO¶2¶-Extrakt aus Tanacetum parthenium
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
GB2340120B (en) * 1998-08-01 2003-06-18 Essential Nutrition Ltd Nettle extract containing phytosterols
DE19844836A1 (de) 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
IT1312342B1 (it) * 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
CN1882354B (zh) * 2003-09-12 2012-07-04 捷通国际有限公司 细胞因子调节剂及相关用法
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
DE102004037002B4 (de) * 2004-07-30 2006-06-14 Chemieanlagenbau Chemnitz Gmbh Verfahren zur Herstellung von Dimethylaminoarglabin-Hydrochlorid
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
US8409637B2 (en) * 2007-06-21 2013-04-02 Puramed Bioscience Inc. Compositions and methods for treating and preventing migrainous headaches and associated symptoms
CN103524520B (zh) * 2013-09-25 2015-12-09 中国人民解放军第四军医大学 一种从植物原料中提取小白菊内酯的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119454A1 (de) * 1981-05-15 1982-12-09 Haarmann & Reimer Gmbh, 3450 Holzminden Verfahren zur herstellung von konzentrierten extrakten aus frischen pflanzen oder teilen davon, insbesondere frischen kuechenkraeutern
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
GB8428747D0 (en) * 1984-11-14 1984-12-27 Hancock K A Products for treatment of human body
FI73962C (fi) * 1985-03-01 1987-12-10 Yhtyneet Paperitehtaat Oy Foerfarande foer framstaellning av vanillin.
FR2629735B1 (fr) * 1988-04-11 1991-03-22 Agronomique Inst Nat Rech Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus
US4996317A (en) * 1988-08-05 1991-02-26 Kraft General Foods, Inc. Caffeine recovery from supercritical carbon dioxide
US5196575A (en) * 1992-02-19 1993-03-23 Hoechst Celanese Corp. Supercritical separation of isomers of functional organic compounds at moderate conditions

Also Published As

Publication number Publication date
ES2099296T5 (es) 2007-10-16
ES2099296T3 (es) 1997-05-16
PL171097B1 (pl) 1997-03-28
ATE150314T1 (de) 1997-04-15
CA2088289C (en) 2002-11-12
EP0553658B2 (de) 2007-02-14
CZ286486B6 (en) 2000-04-12
UA26917C2 (uk) 1999-12-29
PL297473A1 (en) 1993-08-09
CN1074927C (zh) 2001-11-21
DK0553658T4 (da) 2007-03-19
DK0553658T3 (da) 1997-04-07
US5466451A (en) 1995-11-14
DE4202657A1 (de) 1993-08-05
CZ8293A3 (en) 1993-12-15
DE4202657C2 (de) 1995-10-12
EP0553658A3 (ru) 1994-02-16
CA2088289A1 (en) 1993-08-01
JP3611869B2 (ja) 2005-01-19
BR9300361A (pt) 1993-08-24
SK279652B6 (sk) 1999-02-11
CN1074615A (zh) 1993-07-28
HU9300069D0 (en) 1993-04-28
RU2104017C1 (ru) 1998-02-10
GR3023202T3 (en) 1997-07-30
EP0553658B1 (de) 1997-03-19
JPH0656683A (ja) 1994-03-01
EP0553658A2 (de) 1993-08-04
DE59305824D1 (de) 1997-04-24
HUT64232A (en) 1993-12-28
SK4693A3 (en) 1993-09-09
MX9300265A (es) 1993-11-01

Similar Documents

Publication Publication Date Title
EG20104A (en) Process for extraction of pharmaceutically active compositions from tanactum parathenium and medicament prepared from them
CA2080223A1 (en) Thiophene sulfonamides useful as carbonic anhydrase inhibitors
RU93004547A (ru) Фармацевтический состав на основе tanacetum partheniom, способ его получения и лекарственное средство на его основе
MY101847A (en) Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof.
MX9602955A (es) Procedimiento para solubizar activos farmaceuticos dificilmente solubles.
MY117344A (en) Process for the preparation of respirable particles.
AU7435194A (en) Rapamycin formulation for IV injection
AU604070B2 (en) Modification of alginates or other uronic acid containing compounds
HU9301990D0 (en) Method for producing inclusion compounds of 5,10-methylene-tetrahydro-folic acid with cyclodextrin
AU8117587A (en) Salt of diclofenac with cyclic organic base and pharmaceutical compositions which contain it
AU2923389A (en) A pharmaceutical composition
AU7795800A (en) Method for supercritical fluid extraction
AU3414989A (en) Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
ES2122837A1 (es) Mezcla gaseosa y procedimiento para prepararla.
ZA943648B (en) Medicament aerosol formulation based on fusafungine a process for its preparation and pharmaceutical compositions containing it
ATE220539T1 (de) Verfahren zur trockenmischungkompression von arzneimitteln
JPS56127320A (en) Gamma-globulin pharmaceutical
JPS5736958A (en) Deodorizing, processing and preparing technique for making krill into food
AU3995095A (en) Method of suppressing adsorption of substances derived from container material on drugs and container
JPS6486833A (en) Coffee-aerosol
Laszczyńska et al. Ultrastructure of epithelial cells in rat's epididymal caput in experimental hyperprolactinemia induced by metoclopramide
JPS6452703A (en) Agricultural and horticultural agent
CA2076527A1 (en) A process for the production of solid forms of active substances and the products obtained in this way
SU1630040A1 (ru) Способ гранулирования лекарственных веществ
CA2153570A1 (en) Pharmaceutical composition for treating nicotine dependence